You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    Volume 33, Issue 2 (March 1988)

    3,4-Methylenedioxymethamphetamine (MDMA) and Other Amphetamine Derivatives

    Published Online: March

    CODEN: JFSOAD

      Format Pages Price  
    PDF 12 $25   ADD TO CART

    Cite this document

    X Add email address send
    X
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word



    Abstract

    As various substances of abuse come under Drug Enforcement Administration (DEA) Schedule restrictions, slightly modified derivatives (designer drugs) replace them. A series of amphetamine derivatives are discussed in this presentation. Applicable analytical methods are presented. Details of cases handled by the office (hospital patients, driving while under the influence/driving under the influence of drugs [DWI/DUID], and medical examiner cases) are discussed.


    Author Information:

    Bost, RO
    Chief toxicologist, Southwestern Institute of Forensic Sciences, Dallas, TX


    Stock #: JFS11977J

    ISSN: 0022-1198

    DOI: 10.1520/JFS11977J

    ASTM International
    is a member of CrossRef.

    Author
    Title 3,4-Methylenedioxymethamphetamine (MDMA) and Other Amphetamine Derivatives
    Symposium , 0000-00-00
    Committee E30